ArticleInternational journal of hematology2021
The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration.
Fumiko Ito et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it